Therapeutic Doses of Oral Methylphenidate Significantly Increase Extracellular Dopamine in the Human Brain
暂无分享,去创建一个
Yu-Shin Ding | Nora D. Volkow | Jean Logan | Joanna S. Fowler | Andrew Gifford | Dinko Franceschi | N. Volkow | Gene-Jack Wang | J. Fowler | J. Logan | Yu-Shin Ding | S. Gatley | L. Maynard | D. Franceschi | A. Gifford | M. Gerasimov | Gene-Jack Wang | Samuel J. Gatley | Madina Gerasimov | Laurence Maynard
[1] G. Rebec,et al. Dopaminergic modulation of glutamate-induced excitations of neurons in the neostriatum and nucleus accumbens of awake, unrestrained rats. , 1996, Journal of neurophysiology.
[2] J. Swanson,et al. Medication treatment strategies in the MTA Study: relevance to clinicians and researchers. , 1996, Journal of the American Academy of Child and Adolescent Psychiatry.
[3] K. Midha,et al. Extensive and enantioselective presystemic metabolism of dl-threo-methylphenidate in humans , 1991, Progress in Neuro-Psychopharmacology and Biological Psychiatry.
[4] I. Waldman,et al. Association and linkage of the dopamine transporter gene and attention-deficit hyperactivity disorder in children: heterogeneity owing to diagnostic subtype and severity. , 1998, American journal of human genetics.
[5] J. Perel,et al. Metabolism and disposition of methylphenidate-14C: studies in man and animals. , 1974, The Journal of pharmacology and experimental therapeutics.
[6] David J. Schlyer,et al. Graphical Analysis of Reversible Radioligand Binding from Time—Activity Measurements Applied to [N-11C-Methyl]-(−)-Cocaine PET Studies in Human Subjects , 1990, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[7] Darin D Dougherty,et al. Dopamine transporter density in patients with attention deficit hyperactivity disorder , 1999, The Lancet.
[8] N. Volkow,et al. Reinforcing effects of psychostimulants in humans are associated with increases in brain dopamine and occupancy of D(2) receptors. , 1999, The Journal of pharmacology and experimental therapeutics.
[9] N. Volkow,et al. Comparison between intraperitoneal and oral methylphenidate administration: A microdialysis and locomotor activity study. , 2000, The Journal of pharmacology and experimental therapeutics.
[10] A. Malhotra,et al. Schizophrenia is associated with elevated amphetamine-induced synaptic dopamine concentrations: evidence from a novel positron emission tomography method. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[11] D. Jasinski,et al. Intravenous methylphenidate abuse. Prototype for prescription drug abuse. , 1991, Archives of internal medicine.
[12] M. Solanto. Neuropsychopharmacological mechanisms of stimulant drug action in attention-deficit hyperactivity disorder: a review and integration , 1998, Behavioural Brain Research.
[13] N. Volkow,et al. Blockade of striatal dopamine transporters by intravenous methylphenidate is not sufficient to induce self-reports of "high". , 1999, The Journal of pharmacology and experimental therapeutics.
[14] N. Volkow,et al. Effects of Blood Flow on [11C]Raclopride Binding in the Brain: Model Simulations and Kinetic Analysis of PET Data , 1994, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[15] J S Fowler,et al. Reproducibility of repeated measures of endogenous dopamine competition with [11C]raclopride in the human brain in response to methylphenidate. , 1999, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[16] D. Charney,et al. Spect imaging of striatal dopamine release after amphetamine challenge in humans: Relationship between subjective effects and dopamine release , 1995, Schizophrenia Research.
[17] N. Volkow,et al. Dopamine transporter occupancies in the human brain induced by therapeutic doses of oral methylphenidate. , 1998, The American journal of psychiatry.
[18] J. Swanson,et al. More frequent diagnosis of attention deficit-hyperactivity disorder. , 1995, The New England journal of medicine.
[19] M. Kuhar,et al. Cocaine receptors on dopamine transporters are related to self-administration of cocaine. , 1987, Science.
[20] P. Seeman,et al. Anti-hyperactivity medication: methylphenidate and amphetamine , 1998, Molecular Psychiatry.
[21] J S Fowler,et al. Striatal binding of the PET ligand 11C‐raclopride is altered by drugs that modify synaptic dopamine levels , 1993, Synapse.
[22] A. Grace,et al. The tonic/phasic model of dopamine system regulation: its relevance for understanding how stimulant abuse can alter basal ganglia function. , 1995, Drug and alcohol dependence.
[23] J. Biederman,et al. Attention-deficit/hyperactivity disorder: a life-span perspective. , 1998, The Journal of clinical psychiatry.
[24] P. Overton,et al. Burst firing in midbrain dopaminergic neurons , 1997, Brain Research Reviews.
[25] G. Koob. Hedonic valence, dopamine and motivation. , 1996, Molecular psychiatry.
[26] W. Oldendorf,et al. Some relationships between addiction and drug delivery to the brain. , 1992, NIDA research monograph.
[27] D. Segal,et al. Effects of Methylphenidate on Extracellular Dopamine, Serotonin, and Norepinephrine: Comparison with Amphetamine , 1997, Journal of neurochemistry.
[28] Jean Logan,et al. Imaging endogenous dopamine competition with [11C]raclopride in the human brain , 1994, Synapse.
[29] C. Schuster,et al. Fixed-interval schedule of cocaine reinforcement: effect of dose and infusion duration. , 1973, Journal of the experimental analysis of behavior.
[30] Klaus Tatsch,et al. Increased striatal dopamine transporter in adult patients with attention deficit hyperactivity disorder: effects of methylphenidate as measured by single photon emission computed tomography , 2000, Neuroscience Letters.
[31] M. Gold,et al. From Coca Leaves to Crack: The Effects of Dose and Routes of Administration in Abuse Liability , 1988 .
[32] J S Fowler,et al. Is methylphenidate like cocaine? Studies on their pharmacokinetics and distribution in the human brain. , 1995, Archives of general psychiatry.
[33] R. Mark Wightman,et al. Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter , 1996, Nature.
[34] J. Lieberman,et al. Behavioral and cardiovascular effects of intravenous methylphenidate in normal subjects and cocaine abusers , 1997 .
[35] F Xavier Castellanos,et al. Cerebrospinal Fluid Homovanillic Acid Predicts Behavioral Response to Stimulants in 45 Boys with Attention Deficit/Hyperactivity Disorder , 1996, Neuropsychopharmacology.
[36] D. Parmelee,et al. Population Pharmacokinetics of Methylphenidate in Children with Attention‐Deficit Hyperactivity Disorder , 1999, Journal of clinical pharmacology.